Publication: Pathological factors evaluating prostate cancer
Authors
Yu, Y.P. ; Luo, J.H.
item.page.secondaryauthor
item.page.director
Publisher
Murcia : F. Hernández
publication.page.editor
publication.page.department
DOI
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Prostate cancer is one of the most prevalent
malignancies for men world wide. However, only a
small fraction of prostate cancer cases are metastasizing
and life-threatening. Even though the detection rate of
prostate cancer has been steadily increased in the last
two decades due to implementation of PSA screening, it
is still not clear what factors govern its clinical
outcomes. In this review, we will discuss several recent
pathological advances that might contribute to the
progression of prostate cancer. In addition, this review
will cover a brief overview on conventional
morphological evaluation of prostate cancer
differentiation
publication.page.subject
Citation
item.page.embargo
Ir a Estadísticas
Sin licencia Creative Commons.